Evidence map›Paper›PMID 36001680›Full record

ArticleScience translational medicine2022

A genetically engineered

Sean C Murphy, Ashley M Vaughan, James G Kublin, Matthew Fishbauger, Annette M Seilie, Kurtis P Cruz, Tracie Mankowski, Melike Firat, Sara Magee, Will Betz and 15 more

Open access · greenAbstract read
In one paragraph

Article in Science translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. CD8Frontiers in immunology · 2024
    Review
  18. Efficacy of aInfection and immunity · 2023
    Article
  19. Malaria Vaccines: Progress to Date.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 1 country.

Sean C MurphyDepartment of Laboratory Medicine and Pathology and Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109, USA.ORCID 0000-0002-2048-0131
Ashley M VaughanCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.ORCID 0000-0001-5815-756X
James G KublinDepartment of Global Health, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0003-1279-3741
Matthew FishbaugerCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Annette M SeilieDepartment of Laboratory Medicine and Pathology and Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109, USA.
Kurtis P CruzDepartment of Laboratory Medicine and Pathology and Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109, USA.
Tracie MankowskiCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Melike FiratCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Sara MageeCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Will BetzCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.ORCID 0000-0001-5709-2223
Heather KainCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Nelly CamargoCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Meseret T HaileCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.ORCID 0000-0002-5512-5260
Janna ArmstrongCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.ORCID 0000-0003-2719-9008
Emma FritzenCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.ORCID 0000-0002-1773-3070
Nina HertoghsCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Sudhir KumarCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.ORCID 0000-0002-2847-393X
D Noah SatherCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.ORCID 0000-0002-9128-172X
Leeya F PinderDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA 98195, USA.
Gregory A DeyeDivision of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, MD, USA.ORCID 0000-0001-5527-4541
Shirley GalbiatiEmmes Company, Rockville, MD, USA.
Casey GeberEmmes Company, Rockville, MD, USA.
Jessica ButtsEmmes Company, Rockville, MD, USA.ORCID 0000-0002-3598-5861
Lisa A JacksonKaiser Permanente Washington Health Research Institute, Seattle, WA, USA.ORCID 0000-0002-1785-0218
Stefan H I KappeCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.ORCID 0000-0003-1540-1731
Infectious Disease Research Institute · USUniversity of Washington · USEmmes (United States) · USKaiser Permanente Washington Health Research Institute · USNational Institute of Allergy and Infectious Diseases · US

Funding

Kaiser Washington VTEU supplement 20-0003UM1AI148373 · NIAID · KAISER FOUNDATION RESEARCH INSTITUTE · PI LISA A JACKSON · 2020 to 2026
$24.4M
NIAID NIH HHS HHSN272201300019CNIAID NIH HHS HHSN272201300019I
6 · The paper itself

Abstract

Genetically engineered live

Indexed as

Insect Bites and StingsMalariaMalaria, FalciparumMalaria VaccinesParasitesAnimalsHumansPlasmodium falciparumSporozoitesVaccines, AttenuatedMalaria VaccinesVaccines, Attenuated

Identifiers

PMID36001680
PMCPMC10423335
OpenAlexW4293103825

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.